A novel lipid metabolic related lncRNA, TINCR, was identified to be significantly overexpressed in nasopharyngeal carcinoma (NPC), and can promote proliferation, metastasis and cisplatin resistance of NPC by affecting ACLY‐mediated de novo lipid biosynthesis. The gene discussed is TINCR; the disease is nasopharyngeal carcinoma.